Finally, a SMART approach for the PDA? One of the thorniest topics in neonatology currently. Some experts seem certain that we can define PDAs that benefit from early treatment. In contrast, the recent trials don't show any clinical benefit in early treated groups compared to controls, and indeed…
Finally, a SMART approach for the PDA?
One of the thorniest topics in neonatology currently. Some experts seem certain that we can define PDAs that benefit from early treatment. In contrast, the recent trials don't show any clinical benefit in early treated groups compared to controls, and indeed usually show an increase in BPD with early treatment, and an increase in mortality with very early treatment. I have posted many times over the last few years about trials of PDA closure. See here and here and here and here Bedside echocardiography has been used to try and define characteristics of the baby and the ductus that might benefit from treatment, but the difficulties in interpretation mean that most of the trials have either just confirmed patency, or have just measured ductus diameter (which isn't much above the limits of resolution of the devices) as a criterion for entry into the trial.
neonatalresearch.org